4//SEC Filing
Esperion Therapeutics, Inc. 4
Accession 0001179110-16-017141
$ESPRCIK 0001434868operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:37 PM ET
Size
5.4 KB
Accession
0001179110-16-017141
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2016-01-04+15,000→ 15,000 totalExercise: $21.65Exp: 2026-01-04→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 4, 2016.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001434868
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:37 PM ET
- Size
- 5.4 KB